Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] price plunged by -1.85 percent to reach at -$0.19. The one-year BCRX stock forecast points to a potential upside of 39.2. The average equity rating for BCRX stock is currently 1.17, trading closer to a bullish pattern in the stock
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] gained 1.44% or 0.12 points to close at $8.44 with a heavy trading volume of 4967780 shares. The daily chart for BCRX points out that the company has recorded 3.18% gains over the past six months. If we look at
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] gained 3.27% or 0.26 points to close at $8.22 with a heavy trading volume of 3306932 shares. The daily chart for BCRX points out that the company has recorded 9.31% gains over the past six months. If we look at
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] stock went on a downward path that fall over -5.32% on Thursday, amounting to a one-week price decrease of less than -12.55%. Over the last 12 months, BCRX stock rose by 33.54%. The one-year Biocryst Pharmaceuticals Inc stock forecast points
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] surged by $0.06 during the normal trading session on while it closed the day at $7.69. Biocryst Pharmaceuticals Inc stock has also gained 1.99% of its value over the past 7 days. However, BCRX stock has inclined by 3.08% in
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] price plunged by -2.69 percent to reach at -$0.23. The one-year BCRX stock forecast points to a potential upside of 47.77. The average equity rating for BCRX stock is currently 1.18, trading closer to a bullish pattern in the stock
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] gained 0.46% or 0.04 points to close at $8.82 with a heavy trading volume of 3654224 shares. The daily chart for BCRX points out that the company has recorded 11.79% gains over the past six months. If we look at
Copyright © 2024, Powered by Smart TechOne
